464 results on '"Patard, J. J."'
Search Results
52. Cancer du rein
53. Diagnóstico y tratamiento de las rupturas de la uretra posterior
54. Tratamiento de los tumores vesicales T1G3
55. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up †
56. Eight year improvement in pathological results after radical prostatectomy
57. Aortic dissection in a patient treated by sunitinib for metastatic renal cell carcinoma
58. Immune response following intravesical bacillus Calmette-Guerin instillations in superficial bladder cancer: a review
59. Traumatismos uretrales agudos en el varón
60. Prostate Biopsy in the staging of prostate cancer
61. Antiviral responses of human Leydig cells to mumps virus infection or poly I:C stimulation
62. Interleukin-6 and vascular endothelial growth factor release by renal cell carcinoma cells impedes lymphocyte–dendritic cell cross-talk
63. Prognostic factors in superficial bladder cancer
64. Mechanisms of action of bacillus Calmette-Guérin in the treatment of superficial bladder cancer
65. A preoperative clinical prognostic model for non-metastatic renal cell carcinoma
66. Prognostic significance of the mode of detection in renal tumours
67. Neuroendocrine component in undifferentiated tumours of the bladder: prognostic value
68. Is renal cell carcinoma in young adults less than 40 years old a different entity?
69. Outcome of radical cystectomy for bladder cancer according to the disease type at presentation
70. A0992 - Machine learning approach to predict pT3a upstaging of clinically localized renal cell carcinoma and oncological outcomes after surgery (UroCCR 15 study)
71. Artificial sphincter insertion after radiotherapy: is it worthwhile?
72. Ultrasound molecular imaging to predict response to sunitinib in a renal carcinoma patient derived xenograft model
73. Facteurs prédictifs et pronostics du cancer du rein à composante sarcomatoïde. Résultats d’une étude UCLA et UroCCR 45
74. Evaluation of local immune response after intravesical bacille Calmette-Guérin treatment for superficial bladder cancer
75. Overall survival and oncological outcomes after partial nephrectomy and radical nephrectomy for cT2a renal tumors: A collaborative international study from the French kidney cancer research network UroCCR
76. Postoperative outcomes of elderly patients undergoing partial nephrectomy: A multicentric-study of the French research network on kidney cancer UroCCR
77. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up †
78. Éditorial
79. Adjuvant sunitinib (SU) in patients (pts) with high risk renal cell carcinoma (RCC): Safety and therapy management in S-TRAC trial
80. S-TRAC adjuvant sunitinib phase 3 trial in patients with high risk renal cell carcinoma: Subgroups analyses by risk factors
81. Impact de l’assistance robotique sur la pratique et les résultats de la chirurgie rénale conservatrice : une expérience monocentrique
82. 677 - Ultrasound molecular imaging to predict response to sunitinib in a renal carcinoma patient derived xenograft model
83. genitourinary tumours, non prostate Phase III trial of sunitinib (SU) vs placebo (PBO) as adjuvant treatment for high-risk renal cell carcinoma (RCC) after nephrectomy (S-TRAC)
84. Thérapies ciblées néo-adjuvantes dans le cancer du rein
85. 405 Comparison of 1,800 robotic and open partial nephrectomies for renal tumors
86. 1092 Imperative indications of nephron sparing technique: Partial nephrectomy vs percutaneous ablative therapy
87. Ischemia is not an independent predictive factor of chronic renal failure after partial nephrectomy in a solitary kidney in patients without pre-operative renal insufficiency
88. An Antigen Recognized by Autologous CTLs on a Human Bladder Carcinoma
89. 1039 - Postoperative outcomes of elderly patients undergoing partial nephrectomy: A multicentric-study of the French research network on kidney cancer UroCCR
90. [CCAFU Recommendations 2013: Renal cancer]
91. RANK/OPG ratio of expression in primary clear-cell renal cell carcinoma is associated with bone metastasis and prognosis in patients treated with anti-VEGFR-TKIs
92. Étude observationnelle descriptive rétrospective d’une consultation multidisciplinaire pour la prise en charge décisionnelle initiale des cancers de la prostate non métastatiques
93. 915 Is laparoscopic partial nephrectomy a safe treatment option for unexpected pT3a renal cell carcinoma?
94. Angiomyolipome avec thrombus de la veine cave inférieure et grossesse : enjeux de la prise en charge urologique
95. 727 From clinically localized to pT3a renal cell carcinoma: What are the predictive factors of unexpected pathologic upstaging?
96. L’ischémie a un impact limité sur la fonction rénale après néphrectomie partielle sur rein unique chez les patients sans insuffisance rénale préopératoire
97. Positive Surgical Margin Appears to Have Negligible Impact on Survival of Renal Cell Carcinomas Treated by Nephron-Sparing Surgery
98. Independent predictors of contralateral metachronous upper urinary tract transitional cell carcinoma after nephroureterectomy: Multi-institutional dataset from three European centers: Original Article: Clinical Investigation
99. 855PD - Adjuvant sunitinib (SU) in patients (pts) with high risk renal cell carcinoma (RCC): Safety and therapy management in S-TRAC trial
100. Presence of systemic symptoms is the foremost predictor of mortality in patients with exclusive nodal metastases
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.